Ovid Therapeutics (OVID) Preferred Shares (2016 - 2023)

Ovid Therapeutics (OVID) has reported Preferred Shares for 7 consecutive years, with $1.0 the latest figure, recorded in Q3 2023.

• For the quarter ending Q3 2023, Preferred Shares changed 0.0% year-over-year to $1.0; the trailing twelve-month figure through Sep 2023 stood at $1.0 (changed 0.0% YoY), and the FY2022 full-year result was $1.0, changed 0.0% from the prior year.
• Preferred Shares held at $1.0 in Q3 2023 per OVID's latest filing, from $1.0 in the prior quarter.
• Across five years, Preferred Shares topped out at $10.0 million in Q1 2020 and bottomed at $1.0 in Q1 2021.
• Historically, Preferred Shares has averaged $526318.1 across 5 years, with a median of $1.0 in 2021.
• The sharpest annual moves came in 2020 and 2021: Preferred Shares surged 333333233.33% in 2020, then sank 100.0% in 2021.
• Over 5 years, Preferred Shares stood at $8.0 in 2019, then plunged by 62.5% to $3.0 in 2020, then plunged by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
• According to Business Quant data, Preferred Shares over the past three periods registered $1.0, $1.0, and $1.0 for Q3 2023, Q2 2023, and Q1 2023 respectively.